BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18448758)

  • 21. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
    Matloff ET; Barnett RE; Bober SL
    Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Your money or your life.
    Westphal SP
    New Sci; 2002 Jul; 175(2351):28-33. PubMed ID: 12625339
    [No Abstract]   [Full Text] [Related]  

  • 23. [Review of the literature on BRCA 1 and BRCA 2].
    Saponara R; Menditto A; Russo G; Musone R; Balbi GC; Balbi C
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):72-4. PubMed ID: 11526726
    [No Abstract]   [Full Text] [Related]  

  • 24. Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.
    Dyer C
    BMJ; 2012 Dec; 345():e8266. PubMed ID: 23223689
    [No Abstract]   [Full Text] [Related]  

  • 25. Caution should be used when interpreting alterations affecting the exon 3 of the BRCA2 gene in breast/ovarian cancer families.
    Díez O; Gutiérrez-Enríquez S; Ramón y Cajal T; Alonso C; Balmaña J; Llort G
    J Clin Oncol; 2007 Nov; 25(31):5035-6; author reply 5036-8. PubMed ID: 17971607
    [No Abstract]   [Full Text] [Related]  

  • 26. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
    Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
    Biglia N; Mariani L; Ponzone R; Sismondi P
    Maturitas; 2008 Jun; 60(2):71-7. PubMed ID: 18472232
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethical issues related to BRCA gene testing in orthodox Jewish women.
    Mor P; Oberle K
    Nurs Ethics; 2008 Jul; 15(4):512-22. PubMed ID: 18515440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Researchers expand genetic epidemiology of BRCA genes.
    Kuska B
    J Natl Cancer Inst; 1997 Jun; 89(12):844-5. PubMed ID: 9196249
    [No Abstract]   [Full Text] [Related]  

  • 30. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.
    Tan DS; Rothermundt C; Thomas K; Bancroft E; Eeles R; Shanley S; Ardern-Jones A; Norman A; Kaye SB; Gore ME
    J Clin Oncol; 2008 Dec; 26(34):5530-6. PubMed ID: 18955455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scaring up patients.
    Ortolon K
    Tex Med; 2008 Aug; 104(8):43-6. PubMed ID: 19306543
    [No Abstract]   [Full Text] [Related]  

  • 34. Charity calls for routine BRCA testing of ovarian cancer patients.
    Wise J
    BMJ; 2013 Sep; 347():f5664. PubMed ID: 24046291
    [No Abstract]   [Full Text] [Related]  

  • 35. [Revocation of the BRCA1 patents by the European Office of Patents: a victory over a rights abuse].
    Stoppa-Lyonnet D; Lenoir G
    Bull Cancer; 2005 Apr; 92(4):410-1. PubMed ID: 15888396
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic variants of uncertain significance: flies in the ointment.
    Domchek S; Weber BL
    J Clin Oncol; 2008 Jan; 26(1):16-7. PubMed ID: 18165634
    [No Abstract]   [Full Text] [Related]  

  • 37. [BRCA gene mutation in breast and ovary tumors].
    Qiu WX; Shen DH; Zhang YX
    Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):59-61. PubMed ID: 12846218
    [No Abstract]   [Full Text] [Related]  

  • 38. The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicing of the transcripts.
    Gutiérrez-Enríquez S; Coderch V; Masas M; Balmaña J; Diez O
    Breast Cancer Res Treat; 2009 Sep; 117(2):461-5. PubMed ID: 18712473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing times for BRCA gene carriers.
    Carlisle D
    Nurs Stand; 2015 Nov; 30(11):17-9. PubMed ID: 26554972
    [No Abstract]   [Full Text] [Related]  

  • 40. [BRCA 1 and BRCA 2 gens in breast cancer].
    Habibović S; Hrgović Z
    Lijec Vjesn; 1998; 120(10-11):342-8. PubMed ID: 19658353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.